[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Epilepsy Market - Global Outlook and Forecast 2021-2027

April 2021 | 103 pages | ID: E242FD747C15EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Epilepsy in Global, including the following market information:

Global Epilepsy Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Epilepsy market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Epilepsy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Epilepsy Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Epilepsy Market Segment Percentages, By Type, 2020 (%)
  • Partial/focal Seizure
  • Generalized Seizure
  • Myoclonus Misses
  • Negative Myoclonus
  • Eyelid Myoclonus
  • Laughter
  • Others
China Epilepsy Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Epilepsy Market Segment Percentages, By Application, 2020 (%)
  • Hospitals
  • Neurology Centers
  • Home Care Settings
  • Ambulatory Surgical Centers
  • Others
Global Epilepsy Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Epilepsy Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Epilepsy Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Epilepsy Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
  • LivaNova
  • Johnson & Johnson Services
  • Eisai
  • GlaxoSmithKline PLC
  • Pfizer
  • UCB SA
  • Medtronic PLC (Ireland)
  • NeuroPace
  • Novartis AG
  • GW Pharmaceuticals
  • Abbott Laboratories
  • Sanofi
  • Sunovion Pharmaceuticals
  • Bausch Health
  • Takeda
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Epilepsy Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Epilepsy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL EPILEPSY OVERALL MARKET SIZE

2.1 Global Epilepsy Market Size: 2021 VS 2027
2.2 Global Epilepsy Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Epilepsy Players in Global Market
3.2 Top Global Epilepsy Companies Ranked by Revenue
3.3 Global Epilepsy Revenue by Companies
3.4 Top 3 and Top 5 Epilepsy Companies in Global Market, by Revenue in 2020
3.5 Global Companies Epilepsy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Epilepsy Players in Global Market
  3.6.1 List of Global Tier 1 Epilepsy Companies
  3.6.2 List of Global Tier 2 and Tier 3 Epilepsy Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Epilepsy Market Size Markets, 2021 & 2027
  4.1.2 Partial/focal Seizure
  4.1.3 Generalized Seizure
  4.1.4 Myoclonus Misses
  4.1.5 Negative Myoclonus
  4.1.6 Eyelid Myoclonus
  4.1.7 Laughter
  4.1.8 Others
4.2 By Type - Global Epilepsy Revenue & Forecasts
  4.2.1 By Type - Global Epilepsy Revenue, 2016-2021
  4.2.2 By Type - Global Epilepsy Revenue, 2022-2027
  4.2.3 By Type - Global Epilepsy Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Epilepsy Market Size, 2021 & 2027
  5.1.2 Hospitals
  5.1.3 Neurology Centers
  5.1.4 Home Care Settings
  5.1.5 Ambulatory Surgical Centers
  5.1.6 Others
5.2 By Application - Global Epilepsy Revenue & Forecasts
  5.2.1 By Application - Global Epilepsy Revenue, 2016-2021
  5.2.2 By Application - Global Epilepsy Revenue, 2022-2027
  5.2.3 By Application - Global Epilepsy Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Epilepsy Market Size, 2021 & 2027
6.2 By Region - Global Epilepsy Revenue & Forecasts
  6.2.1 By Region - Global Epilepsy Revenue, 2016-2021
  6.2.2 By Region - Global Epilepsy Revenue, 2022-2027
  6.2.3 By Region - Global Epilepsy Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Epilepsy Revenue, 2016-2027
  6.3.2 US Epilepsy Market Size, 2016-2027
  6.3.3 Canada Epilepsy Market Size, 2016-2027
  6.3.4 Mexico Epilepsy Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Epilepsy Revenue, 2016-2027
  6.4.2 Germany Epilepsy Market Size, 2016-2027
  6.4.3 France Epilepsy Market Size, 2016-2027
  6.4.4 U.K. Epilepsy Market Size, 2016-2027
  6.4.5 Italy Epilepsy Market Size, 2016-2027
  6.4.6 Russia Epilepsy Market Size, 2016-2027
  6.4.7 Nordic Countries Epilepsy Market Size, 2016-2027
  6.4.8 Benelux Epilepsy Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Epilepsy Revenue, 2016-2027
  6.5.2 China Epilepsy Market Size, 2016-2027
  6.5.3 Japan Epilepsy Market Size, 2016-2027
  6.5.4 South Korea Epilepsy Market Size, 2016-2027
  6.5.5 Southeast Asia Epilepsy Market Size, 2016-2027
  6.5.6 India Epilepsy Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Epilepsy Revenue, 2016-2027
  6.6.2 Brazil Epilepsy Market Size, 2016-2027
  6.6.3 Argentina Epilepsy Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Epilepsy Revenue, 2016-2027
  6.7.2 Turkey Epilepsy Market Size, 2016-2027
  6.7.3 Israel Epilepsy Market Size, 2016-2027
  6.7.4 Saudi Arabia Epilepsy Market Size, 2016-2027
  6.7.5 UAE Epilepsy Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 LivaNova
  7.1.1 LivaNova Corporate Summary
  7.1.2 LivaNova Business Overview
  7.1.3 LivaNova Epilepsy Major Product Offerings
  7.1.4 LivaNova Epilepsy Revenue in Global (2016-2021)
  7.1.5 LivaNova Key News
7.2 Johnson & Johnson Services
  7.2.1 Johnson & Johnson Services Corporate Summary
  7.2.2 Johnson & Johnson Services Business Overview
  7.2.3 Johnson & Johnson Services Epilepsy Major Product Offerings
  7.2.4 Johnson & Johnson Services Epilepsy Revenue in Global (2016-2021)
  7.2.5 Johnson & Johnson Services Key News
7.3 Eisai
  7.3.1 Eisai Corporate Summary
  7.3.2 Eisai Business Overview
  7.3.3 Eisai Epilepsy Major Product Offerings
  7.3.4 Eisai Epilepsy Revenue in Global (2016-2021)
  7.3.5 Eisai Key News
7.4 GlaxoSmithKline PLC
  7.4.1 GlaxoSmithKline PLC Corporate Summary
  7.4.2 GlaxoSmithKline PLC Business Overview
  7.4.3 GlaxoSmithKline PLC Epilepsy Major Product Offerings
  7.4.4 GlaxoSmithKline PLC Epilepsy Revenue in Global (2016-2021)
  7.4.5 GlaxoSmithKline PLC Key News
7.5 Pfizer
  7.5.1 Pfizer Corporate Summary
  7.5.2 Pfizer Business Overview
  7.5.3 Pfizer Epilepsy Major Product Offerings
  7.5.4 Pfizer Epilepsy Revenue in Global (2016-2021)
  7.5.5 Pfizer Key News
7.6 UCB SA
  7.6.1 UCB SA Corporate Summary
  7.6.2 UCB SA Business Overview
  7.6.3 UCB SA Epilepsy Major Product Offerings
  7.6.4 UCB SA Epilepsy Revenue in Global (2016-2021)
  7.6.5 UCB SA Key News
7.7 Medtronic PLC (Ireland)
  7.7.1 Medtronic PLC (Ireland) Corporate Summary
  7.7.2 Medtronic PLC (Ireland) Business Overview
  7.7.3 Medtronic PLC (Ireland) Epilepsy Major Product Offerings
  7.4.4 Medtronic PLC (Ireland) Epilepsy Revenue in Global (2016-2021)
  7.7.5 Medtronic PLC (Ireland) Key News
7.8 NeuroPace
  7.8.1 NeuroPace Corporate Summary
  7.8.2 NeuroPace Business Overview
  7.8.3 NeuroPace Epilepsy Major Product Offerings
  7.8.4 NeuroPace Epilepsy Revenue in Global (2016-2021)
  7.8.5 NeuroPace Key News
7.9 Novartis AG
  7.9.1 Novartis AG Corporate Summary
  7.9.2 Novartis AG Business Overview
  7.9.3 Novartis AG Epilepsy Major Product Offerings
  7.9.4 Novartis AG Epilepsy Revenue in Global (2016-2021)
  7.9.5 Novartis AG Key News
7.10 GW Pharmaceuticals
  7.10.1 GW Pharmaceuticals Corporate Summary
  7.10.2 GW Pharmaceuticals Business Overview
  7.10.3 GW Pharmaceuticals Epilepsy Major Product Offerings
  7.10.4 GW Pharmaceuticals Epilepsy Revenue in Global (2016-2021)
  7.10.5 GW Pharmaceuticals Key News
7.11 Abbott Laboratories
  7.11.1 Abbott Laboratories Corporate Summary
  7.11.2 Abbott Laboratories Business Overview
  7.11.3 Abbott Laboratories Epilepsy Major Product Offerings
  7.11.4 Abbott Laboratories Epilepsy Revenue in Global (2016-2021)
  7.11.5 Abbott Laboratories Key News
7.12 Sanofi
  7.12.1 Sanofi Corporate Summary
  7.12.2 Sanofi Business Overview
  7.12.3 Sanofi Epilepsy Major Product Offerings
  7.12.4 Sanofi Epilepsy Revenue in Global (2016-2021)
  7.12.5 Sanofi Key News
7.13 Sunovion Pharmaceuticals
  7.13.1 Sunovion Pharmaceuticals Corporate Summary
  7.13.2 Sunovion Pharmaceuticals Business Overview
  7.13.3 Sunovion Pharmaceuticals Epilepsy Major Product Offerings
  7.13.4 Sunovion Pharmaceuticals Epilepsy Revenue in Global (2016-2021)
  7.13.5 Sunovion Pharmaceuticals Key News
7.14 Bausch Health
  7.14.1 Bausch Health Corporate Summary
  7.14.2 Bausch Health Business Overview
  7.14.3 Bausch Health Epilepsy Major Product Offerings
  7.14.4 Bausch Health Epilepsy Revenue in Global (2016-2021)
  7.14.5 Bausch Health Key News
7.15 Takeda
  7.15.1 Takeda Corporate Summary
  7.15.2 Takeda Business Overview
  7.15.3 Takeda Epilepsy Major Product Offerings
  7.15.4 Takeda Epilepsy Revenue in Global (2016-2021)
  7.15.5 Takeda Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. Epilepsy Market Opportunities & Trends in Global Market
Table 2. Epilepsy Market Drivers in Global Market
Table 3. Epilepsy Market Restraints in Global Market
Table 4. Key Players of Epilepsy in Global Market
Table 5. Top Epilepsy Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Epilepsy Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Epilepsy Revenue Share by Companies, 2016-2021
Table 8. Global Companies Epilepsy Product Type
Table 9. List of Global Tier 1 Epilepsy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Epilepsy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Epilepsy Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Epilepsy Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Epilepsy Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Epilepsy Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Epilepsy Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Epilepsy Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Epilepsy Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Epilepsy Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Epilepsy Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Epilepsy Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Epilepsy Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Epilepsy Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Epilepsy Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Epilepsy Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Epilepsy Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Epilepsy Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Epilepsy Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Epilepsy Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Epilepsy Revenue, (US$, Mn), 2022-2027
Table 30. LivaNova Corporate Summary
Table 31. LivaNova Epilepsy Product Offerings
Table 32. LivaNova Epilepsy Revenue (US$, Mn), (2016-2021)
Table 33. Johnson & Johnson Services Corporate Summary
Table 34. Johnson & Johnson Services Epilepsy Product Offerings
Table 35. Johnson & Johnson Services Epilepsy Revenue (US$, Mn), (2016-2021)
Table 36. Eisai Corporate Summary
Table 37. Eisai Epilepsy Product Offerings
Table 38. Eisai Epilepsy Revenue (US$, Mn), (2016-2021)
Table 39. GlaxoSmithKline PLC Corporate Summary
Table 40. GlaxoSmithKline PLC Epilepsy Product Offerings
Table 41. GlaxoSmithKline PLC Epilepsy Revenue (US$, Mn), (2016-2021)
Table 42. Pfizer Corporate Summary
Table 43. Pfizer Epilepsy Product Offerings
Table 44. Pfizer Epilepsy Revenue (US$, Mn), (2016-2021)
Table 45. UCB SA Corporate Summary
Table 46. UCB SA Epilepsy Product Offerings
Table 47. UCB SA Epilepsy Revenue (US$, Mn), (2016-2021)
Table 48. Medtronic PLC (Ireland) Corporate Summary
Table 49. Medtronic PLC (Ireland) Epilepsy Product Offerings
Table 50. Medtronic PLC (Ireland) Epilepsy Revenue (US$, Mn), (2016-2021)
Table 51. NeuroPace Corporate Summary
Table 52. NeuroPace Epilepsy Product Offerings
Table 53. NeuroPace Epilepsy Revenue (US$, Mn), (2016-2021)
Table 54. Novartis AG Corporate Summary
Table 55. Novartis AG Epilepsy Product Offerings
Table 56. Novartis AG Epilepsy Revenue (US$, Mn), (2016-2021)
Table 57. GW Pharmaceuticals Corporate Summary
Table 58. GW Pharmaceuticals Epilepsy Product Offerings
Table 59. GW Pharmaceuticals Epilepsy Revenue (US$, Mn), (2016-2021)
Table 60. Abbott Laboratories Corporate Summary
Table 61. Abbott Laboratories Epilepsy Product Offerings
Table 62. Abbott Laboratories Epilepsy Revenue (US$, Mn), (2016-2021)
Table 63. Sanofi Corporate Summary
Table 64. Sanofi Epilepsy Product Offerings
Table 65. Sanofi Epilepsy Revenue (US$, Mn), (2016-2021)
Table 66. Sunovion Pharmaceuticals Corporate Summary
Table 67. Sunovion Pharmaceuticals Epilepsy Product Offerings
Table 68. Sunovion Pharmaceuticals Epilepsy Revenue (US$, Mn), (2016-2021)
Table 69. Bausch Health Corporate Summary
Table 70. Bausch Health Epilepsy Product Offerings
Table 71. Bausch Health Epilepsy Revenue (US$, Mn), (2016-2021)
Table 72. Takeda Corporate Summary
Table 73. Takeda Epilepsy Product Offerings
Table 74. Takeda Epilepsy Revenue (US$, Mn), (2016-2021)

LIST OF FIGURES

Figure 1. Epilepsy Segment by Type
Figure 2. Epilepsy Segment by Application
Figure 3. Global Epilepsy Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Epilepsy Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Epilepsy Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Epilepsy Revenue in 2020
Figure 8. By Type - Global Epilepsy Revenue Market Share, 2016-2027
Figure 9. By Application - Global Epilepsy Revenue Market Share, 2016-2027
Figure 10. By Region - Global Epilepsy Revenue Market Share, 2016-2027
Figure 11. By Country - North America Epilepsy Revenue Market Share, 2016-2027
Figure 12. US Epilepsy Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Epilepsy Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Epilepsy Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Epilepsy Revenue Market Share, 2016-2027
Figure 16. Germany Epilepsy Revenue, (US$, Mn), 2016-2027
Figure 17. France Epilepsy Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Epilepsy Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Epilepsy Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Epilepsy Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Epilepsy Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Epilepsy Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Epilepsy Revenue Market Share, 2016-2027
Figure 24. China Epilepsy Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Epilepsy Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Epilepsy Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Epilepsy Revenue, (US$, Mn), 2016-2027
Figure 28. India Epilepsy Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Epilepsy Revenue Market Share, 2016-2027
Figure 30. Brazil Epilepsy Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Epilepsy Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Epilepsy Revenue Market Share, 2016-2027
Figure 33. Turkey Epilepsy Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Epilepsy Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Epilepsy Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Epilepsy Revenue, (US$, Mn), 2016-2027
Figure 37. LivaNova Epilepsy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Johnson & Johnson Services Epilepsy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Eisai Epilepsy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. GlaxoSmithKline PLC Epilepsy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Pfizer Epilepsy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. UCB SA Epilepsy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Medtronic PLC (Ireland) Epilepsy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. NeuroPace Epilepsy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Novartis AG Epilepsy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. GW Pharmaceuticals Epilepsy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Abbott Laboratories Epilepsy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Sanofi Epilepsy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Sunovion Pharmaceuticals Epilepsy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Bausch Health Epilepsy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)


More Publications